	Identification of diagnostic and prognostic biomarkers in lung adenocarcinoma through integrated bioinformatics analysis and real time PCR validation. Sci Rep Hossein Zadeh R, Hossein Zadeh R, Hajimoradi M, Islampanah M, Zarimeidani F, Rahmati R, Ahmadinia M, Bahrami N, Mohamadnia A, Shafaghi S, Nazari E. PMID: 41617774 [PubMed - as supplied by publisher]
	Investigation of the Relationship Between Physical Activity, Hope, Symptom Burden, and Health-Related Quality of Life in Lung Cancer via a Moderated Mediation Model. Psychooncology Zhang Z, Sun X, Chen Y, Chen A, Yang X, Lan Y, Wang Q, Hu G, Cheng S. PMID: 41617649 [PubMed - indexed for MEDLINE]
	Effect of multi-strain probiotics on enhancing apoptosis in lung cancer cells A549. Med J Malaysia Gondokesumo ME, Lesmana R, Geson GR, Anggara IGY, Kirtishanti A. PMID: 41617515 [PubMed - indexed for MEDLINE]
	Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status. Anticancer Res Yamaguchi Y, Yoshida T, Higashiyama RI, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Ohe Y. PMID: 41617462 [PubMed - indexed for MEDLINE]
	First-Line Afatinib 30 mg Versus 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan. Anticancer Res Hung HY, Lee TH, Chuang CH, Lee MH, Wu KL, Kuo CY, Huang HL, Huang CW, Tsai YC, Hung JY, Chong IW, Yang CJ. PMID: 41617459 [PubMed - indexed for MEDLINE]
	Amlodipine Suppresses Lung Metastasis by Increasing Cell Stiffness. Anticancer Res Uchiyama T, Asanuma K, Kita K, Okamoto T, Kawamoto E, Adachi R, Nakata K, Matsuyama Y, Hagi T, Nakamura T, Shimaoka M, Hasegawa M. PMID: 41617444 [PubMed - indexed for MEDLINE]
	Prognostic Factors for Pulmonary Metastasectomy for Colorectal Cancer: A Propensity Score Matching Analysis. Anticancer Res Okado S, Nakamura S, Sugihara M, Kinoshita F, Imamura Y, Nomata Y, Takenaka H, Watanabe H, Kawasumi Y, Nakanishi K, Kadomatsu Y, Ueno H, Kato T, Mizuno T, Taniguchi T, Chen-Yoshikawa TF. PMID: 41617442 [PubMed - indexed for MEDLINE]
	Clinicopathologic Predictors of Outcome and Implications for Adjuvant Therapy in Pathologic Stage II Non-small Cell Lung Cancer. Anticancer Res Shen YW, Lee TH, Hung HY, Liu YW, Lee JY, Lo YT, Lai WA, Kao SY, Li YH, Liu CH, Yang CJ. PMID: 41617420 [PubMed - indexed for MEDLINE]
	Deep Learning-Based Virtual Elastin Staining Improves Visceral Pleural Invasion Assessment in Lung Cancer. Mod Pathol Wang CL, Zhang L, Zou LF, Cao XJ, Wang LJ, Li JW, Xiong JB, Ouyang X, Luo YY, He L, Peng Y, Deng T, Li M, Gao MN, Peng L, Yu SS. PMID: 41616975 [PubMed - as supplied by publisher]
	'Letter to Editor: Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-small Cell Lung Cancer: A Retrospective Real-World Study'. Clin Oncol (R Coll Radiol) Irfan A. PMID: 41616569 [PubMed - as supplied by publisher]
	Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial. ESMO Open Moinard-Butot F, Barbe-Richaud JB, Lasvergnas J, Ancel J, Justeau G, Le Floch H, Somme L, Chouaid C, Bylicki O, Schott R. PMID: 41616390 [PubMed - as supplied by publisher]
	Effects of pulmonary rehabilitation in people with lung cancer after lung resection: a systematic review and meta-analysis. J Cancer Surviv Wang Q, Liu Z, Qi L, Chair SY, Gao R. PMID: 41615632 [PubMed - as supplied by publisher]
	Prophylactic Cranial Irradiation in Small Cell Lung Cancer: Evolution of Evidence, Current Status, and Future Directions. Curr Issues Mol Biol Mamidanna S, Bhandari M, Shah C, Bazile L, Gill SK, Riaz A, Narra LR, Parikh S, Shalaby A, Patel M, Sherwani ZK, Kim J, Deek MP, Jabbour SK, Kumar R. PMID: 41614762 [PubMed]
	Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial. Curr Med Res Opin Cheng Y, Qin T, Chen C, B Barnes F, Barnes G. PMID: 41614649 [PubMed - as supplied by publisher]
	A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer. Oncol Res Cai R, Hu S, Li F, Sha H, Zhou G, Fang Y. PMID: 41613809 [PubMed - indexed for MEDLINE]
	Progression on Mechanism and Therapeutic Implications of Neddylation in Lung Cancer. Oncol Res Zou J, Lu Y, Li J, Zhou Z, Peng F, Qiu P, Tang H, Peng C. PMID: 41613808 [PubMed - indexed for MEDLINE]
	Prognostic Value of Circulating Tumor Cells and Cancer Associated Macrophage-Like Cells in Metastatic Non-Small Cell Lung Cancer Patients: A Retrospective Exploratory Analysis. Oncol Res Siringo M, Meo M, Gelibter AJ, Nicolazzo C, Gazzaniga P. PMID: 41613790 [PubMed - indexed for MEDLINE]
	Progress and prospects of organoids in the pathogenesis of lung cancer and screening of antitumor drugs. Front Oncol Li Y, Shang Y, Zhang N, Li J, Yang Z. PMID: 41613561 [PubMed]
	Risk factors for postoperative venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis. Front Med (Lausanne) Fu J, Zhou Y, Zhang F, Lv R, Hu L, Zhang H. PMID: 41613334 [PubMed]
	NIR-II fluorescence in lung cancer: advancing precision diagnosis and image-guided therapy. Front Chem Yang Y, Fu J, Xie R, Wang C, Wang S, Wen L, Yang Y, Liu C, Yi G, Yu L, Zhou H. PMID: 41613270 [PubMed]

Articles 1 - 20 / 156842

Page 1 of 7843



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy